T cells and natural killer (NK)-cells are derived from pluripotent stem cells and can be distinguished by the expression of various marker proteins. The most important markers are the rearranged T-cell receptor and specific NK-cell receptors. In addition, there is a distinct entity of cells expressing both markers; these cells are called NK/T cells. The immunoprofiles of seven bona fide malignant NK cell lines and five NK/T cell lines have been described earlier in detail. 1 Expression profiling showed that NK and NK/T cell lines have identical profiles of a set of transcription factors, distinct from those of T-acute lymphoblastic leukemia (ALL) or B-cell precursor leukemia-derived cell lines. 2 Here, we applied the methylation-specific multiplex ligationdependent probe amplification (MS-MLPA) assay to find out whether the methylation status of a defined set of tumor suppressor genes (TSG) allows for the discrimination of T-ALL from NK-cell-derived cell lines. 3 Promoter hypermethylation of tumor suppressor genes is often seen in malignant diseases and, according to the widely held view, contributes to the rise of malignant cell clones by keeping the tumor suppressors at a low level. 4 Specific profiles of hypermethylated CpG islands have been described, which are unique for different neoplasias. [5] [6] [7] More recently, gene methylation patterns have also been used to identify lymphomatous entities. 8, 9 In this study, MS-MLPA assay showed that the promoter of one of the twenty-four tumor suppressor genes that was analyzedF Death-associated protein kinase 1 (DAPK1)Fwas typically methylated in NK and NK/T cell lines, but not in T-ALL cell lines (Table 1) . DAPK1 is a Ca 2 þ /calmodulin-dependent serinethreonine kinase and acts as a positive mediator of interferon-g-, tumor necrosis factor-a-and FAS-induced apoptosis. 10, 11 Methylation-specific PCR of bisulfite-converted DNA confirmed the MS-MLPA assay results suggesting that the methylation status of DAPK1 might help to differentiate between NK-and NK/T cells on the one hand and T cells on the other (Figure 1 , Table 1 ). However, not all T-cells show the unmethylated form of DAPK1: cell lines KARPAS-299, L-82 Table 1 DAPK1 methylation and expression in NK-NK/T and T-cell lines and SUP-M2Fall T-cell type anaplastic large cell lymphoma (ALCL) cell linesFharbor a methylated DAPK1 promoter (Table 1) . 12 This observation supports the finding of DAPK1 hypermethylation in some T-cell malignancies, and not only in NK-and NK/T cells. 13 However, in contrast to this earlier study, our work was not restricted to lymphomas. We show that T-ALL cell lines, in contrast to T-cell lymphoma-derived cell lines and NK-or NK/T cell lines, exhibit an unmethylated DAPK1 promoter ( Figure 1 , Table 1 ). These results support and extend an earlier study reporting low frequency of DAPK1 methylation in primary T-ALL cells. Table 1. DAPK1 showed an inverse correlation between promoter methylation and gene expression consistent with epigenetic gene regulation (Figure 2a , Table 1 ). The predictive value for true DAPK1 methylation was 1.0, sensitivity 0.86 and accuracy of the classifier 0.95. T-ALL cell lines on an average showed more than 100-fold higher DAPK1 expression levels than did NK, NK/T-and T-cell lymphoma cell lines (Figure 2b ). Western blot analysis confirmed cell type-specific DAPK1 expression also on the protein level (Figure 2c, Table 1 ).
To verify the epigenetic regulation of DAPK1, we applied the DNA demethylating agent 5-Aza-2 0 deoxycytidine (Aza). Aza treatment for 4 days at 5 mM induced a DAPK1 mRNA expression in the DAPK1-methylated cell lines (KARPAS-299, L-82, YT) more than 200-fold. It has recently been described that the transcriptional repressor DAXX suppresses DAPK1 by the induction of DNA hypermethylation. 17 We performed quantitative PCR to find out whether the DAPK1 hypermethylated cell lines (NK, NK/T and T-ALCL) had substantially higher expression levels of DAXX than the unmethylated T-ALL cell lines. This is not the case; DAXX is constitutively, and to a similar extent, expressed in all cell lines tested (Table 1) . These results suggest that the differences in DAPK1 methylation between T-ALL and NK cell lines are not the result of a differential DAXX expression.
In summary, the hypermethylation of DAPK1 differentiates NK cell lines from T-ALL derived cell lines. The different DAPK1 methylation patterns in the lymphomatous entities cannot simply be explained by different expression levels of DAXX, a transcriptional repressor that recruits DNA methyltransferases to target promoters. In situ localization of follicular lymphoma (ISLFL) is a recently identified pathologic entity in which monoclonal follicle center cells that show strong staining for bcl-2 colonize reactive germinal centers that are negative for bcl-2. Whether this finding represents a preneoplastic event or an early stage of follicular lymphoma (FL) remains unclear. We present a case of a 60-yearold male with ISLFL in a mesenteric lymph node. Although there was no clinical or additional pathologic evidence of FL, peripheral blood testing by PCR amplification detected the same BCL-2/IGH gene rearrangement found in the mesenteric lymph node. This case provides further insight into the pathophysiology of early FL.
A 60-year-old male was examined for a prolonged history of dyspepsia. Gastroscopy showed moderate chronic duodenitis. Computed tomography imaging of the abdomen revealed central mesenteric lymphadenopathy (subcentimeter) with associated mesenteric fat stranding. Laparoscopic biopsy of the mesenteric lymph node was undertaken.
The lymph node parenchyma predominantly contained lymphoid follicles with preserved mantle zones and germinal centers. A few follicles, by contrast, lacked well-defined germinal centers and contained a monotonous population of small lymphoid cells and no tingible body macrophages. The interfollicular areas featured a mixed population of small
